390 results on '"Wendel, Hans-Guido"'
Search Results
2. Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma
3. EIF1AX and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC
4. Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (−) and the eIF4A-inhibitor Silvestrol
5. CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas
6. The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing
7. The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase
8. NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death
9. O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth
10. Emerging epigenetic-modulating therapies in lymphoma
11. Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma
12. Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
13. Data from EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC
14. Supplementary Figures and Data from Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
15. Supplementary Table S5 from CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas
16. Supplementary Data from EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC
17. Supplementary Table 3 from Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
18. Supplementary Table S3 from EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC
19. Data from Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
20. Data from CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas
21. Data from Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
22. Figure S1, Figure S2, Figure S3, Figure S4 from Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
23. Supplementary Figures S1 - S14 from CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas
24. Table S1, Table S2, Table S3, Table S4 from Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
25. Supplementary Table 4 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
26. Supplementary Table 2 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
27. Supplementary figure S4 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
28. Supplementary Table 1 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
29. Supplementary Table 3 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
30. The cat-and-mouse game of BTK inhibition
31. Comparing the Effects of Rocaglates on Energy Metabolism and Immune Modulation on Cells of the Human Immune System
32. The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia
33. Rapamycin-Induced Feedback Activation of eIF4E-EIF4A Dependent mRNA Translation in Pancreatic Cancer
34. TPX2 as Key Downstream Target of the eIF4A Controlled Translational Program in MYCN Driven Neuroblastoma
35. Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation
36. A Rapid Translational Immune Response Program in CD8 Memory T Lymphocytes
37. Abstract PO029: Targeting non-canonical Hippo pathway in NRF2-mutant liver cancer
38. Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines
39. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development
40. Transcriptional and Translational Dynamics of Zika and Dengue Virus Infection
41. Abstract 835: Estrogen receptor expression and ER dependent breast tumor growth are dependent on translation initiation factor EIF4A
42. Abstract 878: Frequent 4EBP1 amplification induces synthetic dependence on FGFR signaling in cancer
43. Abstract 3731: Epigenetic control of tumor cell killing by natural killer cells
44. Abstract 359: Pharmacologically induced polyploidy triggers BCL2 dependence in lymphomas
45. mTORC1 Promotes Survival through Translational Control of Mcl-1
46. The Eph-Receptor A7 Is a Soluble Tumor Suppressor for Follicular Lymphoma
47. Frequent 4EBP1 Amplification Induces Synthetic Dependence on FGFR Signaling in Cancer
48. Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity
49. Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity
50. Loss of p53 Impedes the Antileukemic Response to BCR-ABL Inhibition
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.